Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke

Guolong Yu, David C Hess, Cesario V. Borlongan

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

We investigated the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and the anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats underwent middle cerebral artery (MCA) occlusion then were randomly treated with either: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle displayed profound motor and neurological impairments at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal motor and neurological functions throughout the test period. Of note, ischemic animals that received low dose CsA plus MP showed significantly less motor and neurological deficits at day 1, but thereafter displayed behavioral impairments. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. This study is the first report to demonstrate partial and transient neuroprotection against stroke by low dose CsA when combined with MP.

Original languageEnglish (US)
Pages (from-to)32-37
Number of pages6
JournalBrain Research
Volume1018
Issue number1
DOIs
StatePublished - Aug 20 2004

Fingerprint

Methylprednisolone
Cyclosporine
Stroke
Neuroprotection
Middle Cerebral Artery Infarction
Neuroprotective Agents
Immunosuppressive Agents
Sprague Dawley Rats
Anti-Inflammatory Agents

Keywords

  • Animal model
  • Brain infarct
  • Cerebral ischemia
  • Disorders of the CNS
  • Functional recovery
  • Immunosuppression
  • Inflammation
  • Ischemia
  • Neuroprotection

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke. / Yu, Guolong; Hess, David C; Borlongan, Cesario V.

In: Brain Research, Vol. 1018, No. 1, 20.08.2004, p. 32-37.

Research output: Contribution to journalArticle

@article{5a0c9e5be87543c58603328c2b974ab4,
title = "Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke",
abstract = "We investigated the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and the anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats underwent middle cerebral artery (MCA) occlusion then were randomly treated with either: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle displayed profound motor and neurological impairments at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal motor and neurological functions throughout the test period. Of note, ischemic animals that received low dose CsA plus MP showed significantly less motor and neurological deficits at day 1, but thereafter displayed behavioral impairments. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. This study is the first report to demonstrate partial and transient neuroprotection against stroke by low dose CsA when combined with MP.",
keywords = "Animal model, Brain infarct, Cerebral ischemia, Disorders of the CNS, Functional recovery, Immunosuppression, Inflammation, Ischemia, Neuroprotection",
author = "Guolong Yu and Hess, {David C} and Borlongan, {Cesario V.}",
year = "2004",
month = "8",
day = "20",
doi = "10.1016/j.brainres.2004.05.056",
language = "English (US)",
volume = "1018",
pages = "32--37",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Combined cyclosporine-A and methylprednisolone treatment exerts partial and transient neuroprotection against ischemic stroke

AU - Yu, Guolong

AU - Hess, David C

AU - Borlongan, Cesario V.

PY - 2004/8/20

Y1 - 2004/8/20

N2 - We investigated the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and the anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats underwent middle cerebral artery (MCA) occlusion then were randomly treated with either: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle displayed profound motor and neurological impairments at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal motor and neurological functions throughout the test period. Of note, ischemic animals that received low dose CsA plus MP showed significantly less motor and neurological deficits at day 1, but thereafter displayed behavioral impairments. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. This study is the first report to demonstrate partial and transient neuroprotection against stroke by low dose CsA when combined with MP.

AB - We investigated the neuroprotective effects of immunosuppressant cyclosporine-A (CsA) and the anti-inflammatory methylprednisolone (MP) in a stroke model. Adult Sprague-Dawley rats underwent middle cerebral artery (MCA) occlusion then were randomly treated with either: low dose CsA, MP, low dose CsA plus MP, high dose CsA, or vehicle. Ischemic animals that received low dose CsA, MP or vehicle displayed profound motor and neurological impairments at days 1-3 after stroke. In contrast, ischemic animals that received high dose CsA exhibited near normal motor and neurological functions throughout the test period. Of note, ischemic animals that received low dose CsA plus MP showed significantly less motor and neurological deficits at day 1, but thereafter displayed behavioral impairments. Histological analysis at 3 days post-stroke revealed that only those ischemic animals treated with high dose CsA had significantly reduced cerebral infarcts. This study is the first report to demonstrate partial and transient neuroprotection against stroke by low dose CsA when combined with MP.

KW - Animal model

KW - Brain infarct

KW - Cerebral ischemia

KW - Disorders of the CNS

KW - Functional recovery

KW - Immunosuppression

KW - Inflammation

KW - Ischemia

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=3242660017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242660017&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2004.05.056

DO - 10.1016/j.brainres.2004.05.056

M3 - Article

VL - 1018

SP - 32

EP - 37

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -